Ocrelizumab reduced the number and size of MS-related cortical lesions ... Lesion activity was examined by fluid attenuated inversion recovery (FLAIR), as well as T1/T2 ratio and AI double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback